Literature DB >> 12525534

Fanconi anaemia.

M D Tischkowitz1, S V Hodgson.   

Abstract

Fanconi anaemia (FA) is an autosomal recessive disease characterised by congenital abnormalities, defective haemopoiesis, and a high risk of developing acute myeloid leukaemia and certain solid tumours. Chromosomal instability, especially on exposure to alkylating agents, may be shown in affected subjects and is the basis for a diagnostic test. FA can be caused by mutations in at least seven different genes. Interaction pathways have been established, both between the FA proteins and other proteins involved in DNA damage repair, such as ATM, BRCA1 and BRCA2, thereby providing a link with other disorders in which defective DNA damage repair is a feature. This review summarises the clinical features of FA and the natural history of the disease, discusses diagnosis and management, and puts the recent molecular advances into the context of the cellular and clinical FA phenotype.

Entities:  

Mesh:

Year:  2003        PMID: 12525534      PMCID: PMC1735271          DOI: 10.1136/jmg.40.1.1

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  135 in total

1.  Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice.

Authors:  Mireille Koomen; Ngan C Cheng; Henri J van de Vrugt; Barbara C Godthelp; Martin A van der Valk; Anneke B Oostra; Malgorzata Z Zdzienicka; Hans Joenje; Fré Arwert
Journal:  Hum Mol Genet       Date:  2002-02-01       Impact factor: 6.150

Review 2.  Fanconi's anemia and malignancies.

Authors:  B P Alter
Journal:  Am J Hematol       Date:  1996-10       Impact factor: 10.047

Review 3.  Fanconi's anaemia and pregnancy.

Authors:  B P Alter; C L Frissora; D S Halpérin; M H Freedman; U Chitkara; E Alvarez; L Lynch; B Adler-Brecher; A D Auerbach
Journal:  Br J Haematol       Date:  1991-03       Impact factor: 6.998

4.  Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia.

Authors:  Elsa Callén; Enrique Samper; María J Ramírez; Amadeu Creus; Ricard Marcos; Juan J Ortega; Teresa Olivé; Isabel Badell; María A Blasco; Jordi Surrallés
Journal:  Hum Mol Genet       Date:  2002-02-15       Impact factor: 6.150

5.  Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa.

Authors:  A J Tipping; T Pearson; N V Morgan; R A Gibson; L P Kuyt; C Havenga; E Gluckman; H Joenje; T de Ravel; S Jansen; C G Mathew
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

6.  Identification of Alu-mediated deletions in the Fanconi anemia gene FAA.

Authors:  O Levran; N A Doggett; A D Auerbach
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

7.  p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia.

Authors:  F Rosselli; A Ridet; T Soussi; E Duchaud; C Alapetite; E Moustacchi
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

8.  Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha.

Authors:  F Rosselli; J Sanceau; E Gluckman; J Wietzerbin; E Moustacchi
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113

9.  Telomere shortening in Fanconi anaemia demonstrated by a direct FISH approach.

Authors:  H Hanson; C G Mathew; Z Docherty; C Mackie Ogilvie
Journal:  Cytogenet Cell Genet       Date:  2001

10.  Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.

Authors:  J R Lo Ten Foe; M A Rooimans; L Bosnoyan-Collins; N Alon; M Wijker; L Parker; J Lightfoot; M Carreau; D F Callen; A Savoia; N C Cheng; C G van Berkel; M H Strunk; J J Gille; G Pals; F A Kruyt; J C Pronk; F Arwert; M Buchwald; H Joenje
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

View more
  70 in total

1.  Clinical vignette: early-onset head and neck cancer: beware of fanconi anaemia!

Authors:  Rolf H Sijmons; Rein P Stulp
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

Review 2.  Topics in pediatric leukemia--Fanconi's anemia: new insights.

Authors:  Noah Federman; Kathleen M Sakamoto
Journal:  MedGenMed       Date:  2005-04-06

3.  Fanconi's anemia in monozygotic twins.

Authors:  Fulton D'Souza; M K Usha; S D Subba Rao
Journal:  Indian J Pediatr       Date:  2007-09       Impact factor: 1.967

4.  RAD51D- and FANCG-dependent base substitution mutagenesis at the ATP1A1 locus in mammalian cells.

Authors:  John M Hinz; Salustra S Urbin; Larry H Thompson
Journal:  Mutat Res       Date:  2009-03-18       Impact factor: 2.433

5.  FANCM regulates DNA chain elongation and is stabilized by S-phase checkpoint signalling.

Authors:  Sarah Luke-Glaser; Brian Luke; Simona Grossi; Angelos Constantinou
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

6.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

7.  Cytogenetic study is not essential in patients with aplastic anemia.

Authors:  Atreyee Dutta; Rajib De; Tuphan K Dolai; Pradip K Mitra; Ajanta Halder
Journal:  Am J Blood Res       Date:  2017-11-01

Review 8.  Oesophageal atresia, tracheo-oesophageal fistula, and the VACTERL association: review of genetics and epidemiology.

Authors:  C Shaw-Smith
Journal:  J Med Genet       Date:  2005-11-18       Impact factor: 6.318

9.  ERCC1 is required for FANCD2 focus formation.

Authors:  Kevin M McCabe; Aaron Hemphill; Yassmine Akkari; Petra M Jakobs; Daniel Pauw; Susan B Olson; Robb E Moses; Markus Grompe
Journal:  Mol Genet Metab       Date:  2008-07-30       Impact factor: 4.797

10.  A 15-year-old girl with pancytopenia and congenital defects.

Authors:  Ahmed M AlSuliman; Kafiah Al Qadaiub
Journal:  Ann Saudi Med       Date:  2009 Jul-Aug       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.